Cedara wins some, loses some

Article

Toronto-based Cedara introduced a new orthopedics desk application July 16. Earlier in the month, the company announced a deal with a major Chinese OEM to supply a user interface for its x-ray products. The good news came, however, on the heels of an

Toronto-based Cedara introduced a new orthopedics desk application July 16. Earlier in the month, the company announced a deal with a major Chinese OEM to supply a user interface for its x-ray products. The good news came, however, on the heels of an announcement that the company has been delisted from the Nasdaq effective July 7.

The newly released Cedara OrthoWorks is a suite of desktop and Web server software solutions designed for orthopedic surgeons. The product allows instant access to digital patient images, surgical planning aids, measurement tools, and a library of digital prosthetic templates.

The product release followed a July 7 announcement that Shan Dong XinHua Medical, one of the largest medical equipment manufacturers in China, will integrate its new x-ray systems with Cedara's I-Acquire DR universal acquisition console application. The Cedara technology allows the acquisition of images from multiple digital detectors and x-ray generators from a single user interface.

Cedara stock is now being traded on the OTC Bulletin Board in the wake of its delisting from the Nasdaq. The move became necessary when Cedara was not able to meet the minimum shareholders' equity requirement. The company's listing on the Toronto Stock Exchange, where most of its shares have historically traded, was not affected.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.